Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc., based in Montréal, Québec, is focused on developing innovative treatments for patients experiencing acute episodes of paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib-RVR). Their investigational product, etripamil, is a novel nasal spray designed for at-home administration, addressing the urgent need for therapies outside the emergency department or hospital setting.
Committed to providing cardiac peace of mind, Milestone Pharmaceuticals endeavors to fill existing therapy gaps for various episodic cardiovascular conditions, including angina. The company recognizes the importance of patient and researcher collaboration in advancing medical breakthroughs through clinical trials, offering appreciation to those who contribute to scientific discovery.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.